Indonesian Political, Business & Finance News

Australia Begins Trial of Caffeine Therapy for Premature Babies

| | Source: Republika Translated from Indonesian | Social Policy
Australia Begins Trial of Caffeine Therapy for Premature Babies
Image: Republika

Researchers in Australia have begun an international clinical trial to determine the safest and most effective dose of caffeine for treating premature babies. The research could change standards of care for premature infants around the world.

The trial, being conducted at Mercy Hospital for Women in Melbourne, is the first study in the world specifically to compare three caffeine-dosing regimens for babies born extremely prematurely. Known as BabyCCINO, it is expected to involve about 4,000 babies in Australia, New Zealand and the UK.

Caffeine has been used for decades to help premature babies breathe. However, doctors still do not know which dose is best for patients. Professor Brett Manley of Mercy Hospital for Women and the University of Melbourne said caffeine plays an important role in stimulating the brains of premature babies to keep them breathing.

“Caffeine stimulates the brain of a premature baby, reminding them to breathe,” Manley said, according to 7NEWS on Wednesday (14 October 2026).

Babies born extremely prematurely can experience pauses in breathing that cause oxygen levels in their bodies to fall. This can sometimes mean they need medical assistance.

Dr Katie Van Schilfgaarde, a consultant neonatologist at Mercy Hospital for Women, said the benefits of caffeine treatment can also be seen after babies leave intensive care. According to her, babies who receive caffeine have better long-term outcomes after leaving intensive care.

Through the BabyCCINO study, researchers hope to find out whether a higher caffeine dose than the one routinely used so far can produce better results. “We suspect that doses even higher than those we routinely use may provide greater benefits,” Manley said.

However, he stressed that this hypothesis must be tested in a large-scale clinical trial to ensure babies receive the safest and most effective treatment.

The study will assess the babies’ health during their hospital treatment. Researchers will also evaluate their growth and development at the age of two to three.

“This is the largest clinical trial of caffeine dosing ever conducted in babies born extremely prematurely,” Manley said.

More from 15 October 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/australia-begins-trial-of-caffeine-therapy-for-premature-babies-1792039884)
Originally published by Republika (https://ameera.republika.co.id/berita/tmxk7n425/australia-mulai-uji-coba-terapi-kafein-untuk-perawatan-bayi-prematur), translated from Indonesian
Print